Skip to main content
Caplight Logo









Polyseq Biotech

Polyseq Biotech

Private
BeijingHealthcare & Life Scienceshttps://polyseq.com/

Last Round

Series B

Mar 16, 2026

Total Funding Raised

$14.37M

Company Overview

Polyseq Biotech is a biotechnology company that develops and manufactures nanopore-based gene sequencing platforms, including sequencers, biochips, and reagents.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

genomic sequencingnext-generation sequencingNGSnanopore sequencingmolecular diagnosticsDNA sequencingRNA sequencingbasecallinggenomics AIbiotech hardwareprecision medicinegenomic datasequencing consumablesbioinformatics toolsrazor-and-blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Polyseq Biotech Comparables

Compare Polyseq Biotech with similar companies based on industry and business-model similarity.

Polyseq Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Geneus Technologies (Chengdu) Co., Ltd.
87%
Anxuyuan Biotechnology (Shenzhen) Co., Ltd.
83%
Qitan Tech
80%

Polyseq Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 16, 2026
Series AMay 12, 2023
AngelJan 7, 2022

Polyseq Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2022

    Led by IDG Capital and Tsinghua Innovation Ventures.

Polyseq Biotech Filings

Explore SEC and related filing metadata, where available.

Polyseq Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Polyseq Biotech's valuation, stock price, and market status.

Is Polyseq Biotech a public or private company?

Polyseq Biotech is a private company.

What is the current stock price of Polyseq Biotech?

Polyseq Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Polyseq Biotech worth (valuation)?

Valuation information for Polyseq Biotech is not publicly available.

Can I buy Polyseq Biotech stock?

Polyseq Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Polyseq Biotech's last funding round?

Funding round information for Polyseq Biotech is not publicly available.

Who are the main investors in Polyseq Biotech?

Investor information for Polyseq Biotech is not publicly disclosed.

Will Polyseq Biotech IPO soon?

No public IPO plans have been announced for Polyseq Biotech.

How can I track Polyseq Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Polyseq Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year Founded2021
Last FundingMar 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?